Stockhub

Biocept, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

15 August 2022

11 August 2022

4 August 2022

  • curprev 23:1823:18, 4 August 2022‎ Paris talk contribs‎ 1,429 bytes +1,429‎ Created page with "Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for soli..." Tag: Visual edit
Retrieved from ‘https://stockhub.co/research/Biocept,_Inc.’